Loading...
NPI 1740262880 · Phoenix, AZ · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Laboratory Corporation Of America is a clinical medical laboratory provider located in Phoenix, Arizona. This profile covers 552 Medicare and 598 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Laboratory Corporation Of America |
| Address | 5005 S 40th St |
| City | Phoenix |
| State | AZ |
| ZIP | 85040 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | November 15, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $265.9M |
| Medicare | $38.5M |
Provider is heavily Medicaid‑weighted: lifetime Medicare revenue is $38.5M compared with $265.9M in Medicaid, indicating the entity operates with a dominant Medicaid revenue base rather than a balanced payer mix. This scale difference suggests strategic dependence on Medicaid test volumes and reimbursement patterns for overall revenue performance.
Medicaid revenue is highly concentrated in molecular and NAAT infectious‑disease testing: the top three Medicaid codes (U0003, 87798, 87591) account for 55.1% of Medicaid revenue, with U0003 alone representing $79.4M (35.0%). That concentration—driven by SARS‑CoV‑2 and other amplified‑probe assays—identifies molecular infectious testing as the primary Medicaid service line.
Medicare revenue shows a narrower but significant concentration in routine clinical laboratory services: the top three Medicare codes account for 31.1% of Medicare revenue, led by 80053 ($2.9M, 11.0%), 36415 ($2.7M, 10.5%), and 80061 ($2.5M, 9.6%). Those codes (comprehensive metabolic panel, specimen collection, and lipid panel) point to high-volume outpatient chemistry and specimen‑processing activity in the Medicare population.
The overall code mix indicates a large centralized reference laboratory operation handling both routine monitoring tests and high-throughput molecular panels. High volumes appear across routine chemistry/hematology/endocrine codes (e.g., 80053, 85025, 83036, 84443) alongside massive NAAT and multiplex testing (e.g., U0003, 87798, 87801), consistent with a lab that processes community-collected specimens at scale.
National competitive standing for Medicare shows dominant volume positions on many routine tests: several Medicare codes are described as “extreme outlier” and rank in the 100th percentile nationally (for example, 80053 ranks #20 of 26416 providers nationally (100th percentile; extreme outlier) and 85025 ranks #20 of 32833 providers nationally (100th percentile; extreme outlier)). These placements indicate the provider is a top national volume performer for common diagnostic panels and routine lab work.
State-level competitive standing in Arizona is strongly dominant for molecular and infectious testing: U0003 ranks #1 of 108 providers in-state (100th percentile; extreme outlier), and multiple NAAT codes such as 87798, 87591, 87491, and 87801 similarly rank #1 in-state (100th percentile; extreme outlier). Those rankings portray the provider as the leading in-state processor for SARS‑CoV‑2 and other high-throughput NAAT testing.
The provider’s billing profile includes multiple codes labeled as statistical outliers or notably above typical volumes across both payers, for example 87999 (nationally ranks #2 of 16; 93th percentile; notably above typical national volume) and many 100th percentile listings. This pattern of repeated “extreme outlier” and “notably above typical” labels underscores unusually large scale versus peers and implies sensitivity to any test-specific reimbursement or utilization policy changes.
NPI tenure confirms an established presence: the NPI was enumerated on 2005-11-15 (~21 years ago), indicating long operational history. Combined with the heavy Medicaid revenue and the concentrated code mix, the tenure supports interpretation of a mature reference‑lab business that has scaled molecular infectious testing and routine laboratory services over many years.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
552 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 287,180 | $10 | $2.9M |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 342,700 | $10 | $2.7M |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 192,690 | $10 | $2.5M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 156,410 | $20 | $2.5M |
| 87999 | Use 87999 to report microbiology procedures that do not have a specific code. | 9,290 | $230 | $2.1M |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 245,310 | $10 | $2M |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 62,070 | $30 | $1.8M |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 128,730 | $10 | $1.3M |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 23,960 | $40 | $958.5K |
| 84153 | The lab analyst performs testing for total prostate specific antigen, PSA, typically on serum or plasma samples using laboratory analyzers. PSA is a protein the prostate gland produces, and… | 40,940 | $20 | $736.9K |
Showing 1–10 of 552
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 552 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
552 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81479 | 4 | 10 | 560 | $3,210 | $17.3M |
| 87999 | 1 | 10 | 9,290 | $230 | $2.1M |
| 87150 | 2 | 10 | 70 | $30 | $1.6M |
| 87798 | 4 | 10 | 650 | $30 | $553.2K |
| 86003 | 1 | 10 | 48,520 | $10 | $302K |
| 82784 | 2 | 10 | 11,640 | $10 | $197.3K |
| G0483 | 21 | 20 | 290 | $240 | $196K |
| 83521 | 2 | 10 | 8,690 | $20 | $174.5K |
| 81490 | 1 | 10 | 210 | $820 | $170.5K |
| U0003 | 3 | 10 | 230 | $70 | $166.6K |
Showing 1–10 of 552
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
598 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 1,134,640 | $70 | $79.4M |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 878,450 | $30 | $24.6M |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 1,241,060 | $20 | $21.1M |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 1,240,450 | $20 | $21.1M |
| 87801 | The lab analyst performs a test for multiple infectious agents using amplified nucleic acid probe technique. | 542,780 | $40 | $20.1M |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 758,830 | $20 | $12.9M |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 286,490 | $30 | $7.2M |
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 117,380 | $50 | $5.3M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 236,650 | $20 | $4.3M |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 674,400 | $10 | $3.4M |
Showing 1–10 of 598
How this provider's Medicaid billing volume and revenue compare to other Arizona providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arizona median
598 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 1 | 110 | 960 | $70 | $1.7M |
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 1 | 10 | 1,620 | $40 | $1.3M |
| 81479 | Use 81479 to report a molecular pathology procedure that does not have a specific code. | 2 | 10 | 1,340 | $200 | $1.2M |
| 80081 | The lab analyst performs an obstetric panel; this panel must include tests for a complete blood count with differential, a hepatitis B surface antigen test, a single–result test for HIV–1 antigens… | 2 | 10 | 17,850 | $30 | $995.7K |
| 81229 | The lab analyst performs the technical lab test using comparative genomic hybridization (CGH) microarray, also referred to as chromosomal microarray (CMA) or molecular karyotype performed by… | 3 | 10 | 1,350 | $670 | $982K |
| 87801 | The lab analyst performs a test for multiple infectious agents using amplified nucleic acid probe technique. | 1 | 20 | 250 | $40 | $915.9K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 2 | 30 | 470 | $20 | $761.9K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 1 | 40 | 190 | $30 | $662.3K |
| 87902 | The lab analyst performs the technical lab test to analyze the specific genotype by nucleic acid of a specimen containing hepatitis C virus. | 2 | 10 | 3,410 | $100 | $493.4K |
| 81420 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell free fetal DNA in maternal blood for genetic sequences of at least the genes on chromosomes 13, 18, and 21,… | 1 | 10 | 1,160 | $170 | $470.1K |
Showing 1–10 of 598
Other providers in the same ZIP code as Laboratory Corporation Of America, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Caris Mpi, Inc. | AZ | Clinical Medical Laboratory | $97.4M | $51.7M |
| New Life Wellness Center LLC | AZ | Public Health or Welfare Agency | $0 | $66M |
| Family And Youth Intervention Services | AZ | Community/Behavioral Health Agency | $0 | $16.2M |
| Nebco Associates, Inc. | AZ | Transportation Broker | $0 | $11.4M |
| Central Clinical Labs Incorporated | AZ | Clinical Medical Laboratory | $3.5M | $6.1M |
| Accupath Diagnostic Laboratories Inc | AZ | Clinical Medical Laboratory | $3.3M | $4.1M |
| Sahar Samaha | AZ | Anatomic Pathology & Clinical Pathology Physician | $906.4K | $0 |
| Joshua Leonard | AZ | Optometrist | $347.1K | $0 |
| Abida Kadi | AZ | Dermatopathology (Pathology) Physician | $267K | $0 |
| Hema Khurana | AZ | Anatomic Pathology & Clinical Pathology Physician | $235.5K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.